Simplify & scale your clinical research program
Profound value for pharma
Yunu extends and diversifies imaging clinical trials by reaching the 80% of patients who have limited access.
On imaging assessments for early phase trials with 100% prospective data capture saving future 3rd party RWE expenditures.
Yunu customers indicate our solution accelerates trials by more than 10%, bringing new therapies to market faster and fueling beneficial innovation.
Yunu retains traceability & provides real-time visibility to all imaging-related trial data and activity.